SICPA AND THE BATAILLON DE MARINS-POMPIERS DE MARSEILLE ARE TESTING AN INNOVATIVE SOLUTION FOR DETECTING PATHOGENS IN AIRCRAFT WASTEWATER

 The Swiss company SICPA, a world leader in identification, traceability and authentication technologies, and the bataillon…

MRIdian Clinical and Research Experience Featured in Nearly 40 Abstracts at ESTRO 2022, the Leading European Radiation Oncology Meeting

ViewRay, Inc. (Nasdaq: VRAY) announced today that the company’s MRIdian MRI-guided radiation therapy system will be featured…

Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2022 and Cash Dividend

Select Medical Holdings Corporation (“Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) today announced results for its…

Reema Health Secures $8M in Seed Funding

MN, Reema Health, a community-based health technology platform, recently earned $8 million in a funding round…

Enhanced Paid Leave Benefit Empowers Employees to Give the Gift of Life

 Fresenius Medical Care North America (FMCNA), the nation’s leading provider of kidney care products and services, today…

Total Brain Enhances Product Functionality

 Total Brain, an applied, integrative neuroscience company, today announced the launch of several new features to…

eHealth Technologies Innovates to Advance Patient Access to Life-Saving Medical Treatment

When time means life or death for patients with serious diagnoses, eHealth Technologies™ drives powerful digital solutions that…

Glycobiology Market: 14.23% Y-O-Y Growth Rate in 2022 | By Application (drug discovery and development, disease diagnostics, and others) and Geography – Global Forecast to 2026

The Glycobiology Market Share is expected to increase by USD 1.13 billionfrom 2021 to 2026, at an accelerated CAGR of 14.84%,…

Cano Health Announces Financial Results for the Fourth Quarter and Full Year 2021

Cano Health, Inc. (“Cano Health” or the “Company”) (NYSE: CANO), a leading value-based primary care provider and…

Neuromuscular Disease Therapeutics Market to Grow by USD 4.46 bn | Technavio

The neuromuscular disease therapeutics market is expected to grow by USD 4.46 bn from 2020 to 2025. The growth momentum…